Related Experiment Video
Updated: May 9, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Metabolically healthy obesity: definitions, determinants and clinical implications
1HRB Centre for Diet and Health Research, Department of Epidemiology and Public Health, Room 4.033, Western Gateway Building, University College Cork, Cork, Ireland, c.phillips@ucc.ie.
The metabolically healthy obese (MHO) phenotype may exist, but standard criteria are lacking, hindering accurate prevalence estimates and comparability. Further research is needed on MHO determinants and intervention effectiveness.
Area of Science:
- Endocrinology
- Metabolic Health
- Obesity Research
Background:
- Obesity is linked to metabolic syndrome, type 2 diabetes, cardiovascular disease, and mortality.
- The metabolically healthy obese (MHO) phenotype suggests some obese individuals may not have metabolic abnormalities.
- Lack of standardized criteria for metabolic health impedes accurate MHO prevalence estimation and study comparability.
Purpose of the Study:
- To review the current understanding of the MHO phenotype.
- To discuss the epidemiology, definitions, and determinants of MHO.
- To explore the implications of MHO for obesity diagnosis, interventions, and treatment.
Main Methods:
- Literature review of existing studies on obesity and metabolic health.
- Analysis of epidemiological data regarding MHO prevalence.
- Synthesis of research on dietary and lifestyle factors influencing metabolic health in obesity.
Main Results:
- Conflicting results exist regarding the long-term cardiometabolic disease risk and mortality in MHO individuals.
- Limited data is available on the specific dietary and lifestyle behaviors that determine the MHO phenotype.
- Current 'one-size-fits-all' obesity interventions are largely unsuccessful.
Conclusions:
- Standardized criteria are needed to define and identify the MHO phenotype accurately.
- Understanding MHO determinants is crucial for personalized obesity management.
- Stratifying obese individuals by metabolic phenotype may lead to more effective interventions.
More Related Videos
06:28A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
Published on: April 28, 2023
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
Related Concept Videos
Obesity
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Type II Diabetes I: Introduction
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Drug Dosing: Obese Patients